Please wait

Exhibit 107

CALCULATION OF FILING FEE TABLES

Form S-3

(Form Type)

ORIC Pharmaceuticals, Inc.

(Exact Name of Registrant as Specified in its Charter)

Table 1: Newly Registered Securities

 

                 
     Security
Type		   Security
Class
Title		   Fee
Calculation
Rule		   Amount
Registered (1)(2)		   Proposed
Maximum
Offering
Price Per
Unit (3)		  

Maximum
Aggregate

Offering
Price

   Fee
Rate		   Amount of
Registration
Fee
 
Newly Registered Securities
                 
Fees to Be Paid   Equity    Common Stock, par value $0.0001 per share   457(c)    19,230,845     $8.63(1)     $165,866,039     0.00015310     $25,395 
           
    Total Offering Amounts     $165,866,039     $25,395
           
    Total Fees Previously Paid         —
           
    Total Fee Offsets         —
           
    Net Fee Due               $25,395

 

(1)

Pursuant to Rule 416(a) of the Securities Act of 1933, as amended, this registration statement shall also cover any additional shares of the registrant’s common stock that become issuable by reason of any stock dividend, stock split, recapitalization or other similar transaction effected without receipt of consideration that increases the number of the registrant’s outstanding shares of common stock.

(2)

This registration statement registers 14,130,313 outstanding shares of common stock of the registrant and 5,100,532 shares of common stock of the registrant issuable upon the exercise of pre-funded warrants issued by the registrant at an exercise price of $0.0001 per share.

(3)

Represents shares that may be sold by the selling stockholders identified in the registration statement. Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(c) under the Securities Act based on the average of the high and low prices of the registrant’s common stock on the Nasdaq Global Select Market on June 4, 2025.